SciLucent Revenue and Competitors
Estimated Revenue & Valuation
- SciLucent's estimated annual revenue is currently $8.4M per year.
- SciLucent's estimated revenue per employee is $155,000
Employee Data
- SciLucent has 54 Employees.
- SciLucent grew their employee count by -10% last year.
SciLucent's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, CMC & Quality | Reveal Email/Phone |
2 | VP, CMC Regulatory Affairs | Reveal Email/Phone |
3 | Director, Human Resources & IT | Reveal Email/Phone |
4 | Manager, CMC Regulatory Affairs | Reveal Email/Phone |
5 | Senior Scientific and Regulatory Advisor | Reveal Email/Phone |
6 | Advisor, Clinical Development and Regulatory Affairs | Reveal Email/Phone |
7 | Senior Toxicology Consultant | Reveal Email/Phone |
SciLucent Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.4M | 9 | -10% | N/A | N/A |
#2 | $4.3M | 28 | 4% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $3.5M | 45 | -52% | $56.5M | N/A |
#5 | $0.3M | 2 | 0% | N/A | N/A |
#6 | $4.5M | 29 | 21% | N/A | N/A |
#7 | $1.9M | 12 | 9% | N/A | N/A |
#8 | $7M | 45 | 5% | N/A | N/A |
#9 | $6.7M | 43 | 5% | N/A | N/A |
#10 | $2M | 13 | -13% | N/A | N/A |
What Is SciLucent?
SciLucent provides FDA-focused regulatory, clinical, nonclinical, CMC, quality, scientific, and management consulting services to healthcare product companies that develop, manufacture and/or market pharmaceuticals, biopharmaceuticals, medical devices, combination products, and dietary supplement ingredients. Since 1998 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.
keywords:N/AN/A
Total Funding
54
Number of Employees
$8.4M
Revenue (est)
-10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 54 | -5% | N/A |
#2 | $7M | 54 | 42% | N/A |
#3 | $15M | 54 | 13% | N/A |
#4 | $7M | 54 | 0% | N/A |
#5 | $7M | 54 | 10% | N/A |